Researchers have devised a simple new test called the Melbourne ASSET Risk Score, that will help clinicians decide whether to use oral or intravenous (IV) antibiotics to treat childhood infections.
In a way to help clinicians in making a better decision regarding antibiotic administration, a simple new test developed by the researchers. The test will help the doctors to determine whether to use oral or intravenous (IV) antibiotics to treat childhood infections.// According to a team from the Murdoch Children's Research Institute (MCRI) in Melbourne, Australia, clinicians often face a difficult choice in how best to treat childhood infections where antibiotics are needed.
‘Making a mistake in the route of administering antibiotics to children can either be detrimental to their health or render unwanted expenses. The Melbourne ASSET Risk Score may offer help in such situations.’
"Using IV antibiotics when they're not needed means unnecessary hospitalizations, risk of complications and a financial burden on families and hospitals," said lead author Laila Ibrahim, a doctoral student at MCRI. "Using oral antibiotics when IV is required risks children becoming more unwell, hence the need to standardize the decision between the two when treating childhood infections," she added.
Developed and validated in children attending The Royal Children's Hospital with a common skin infection, the Melbourne ASSET Risk Score is the first clinical risk score to help clinicians decide between IV and oral antibiotics in children.
The findings are published in the journal Pediatrics.
The team developed the risk score with 285 children aged six months to 18 years having cellulitis -- a common skin infection for which the choice between oral and IV antibiotics is unclear.
Advertisement
While developed for cellulitis, the researchers said the risk score, which uses features that can be observed in the child and no extra invasive tests, could be adapted for other settings and different childhood infections.
Advertisement
Source-IANS